Literature DB >> 9245279

Validity of the Beck Depression Inventory, MMPI, and Rorschach in assessing adolescent depression

.   

Abstract

The purpose of the present study was to assess the validity of the Beck Depression Inventory (BDI), the MMPI Depression scale (MMPI-D), and the Rorschach Depression Index (DEPI) in measuring adolescent depression. Retroactive charts of 118 hospitalized adolescents were divided into depressed (n=66) and nondepressed (n=52) groups, based on the psychiatric diagnosis. Results indicated significant differences between the means of the two groups on the BDI (p<0.00001) and the MMPI-D scale (p<0.0001), establishing concurrent validity for these measures of depression. Correlation coefficients among the three measures of depression indicated a significant relationship between the BDI and the MMPI-D scale (p<0.01), again supporting the concurrent validity of these instruments. Predictive utility was determined for each of the three instruments individually and in combination, with results indicating that the BDI and MMPI-D scales alone and in combination significantly discriminated depressed from nondepressed adolescents. The MMPI-D scale alone was the most accurate measure in classifying the participants into their respective groups. The DEPI was not established as a valid predictor of adolescent depression.

Entities:  

Year:  1996        PMID: 9245279     DOI: 10.1006/jado.1996.0021

Source DB:  PubMed          Journal:  J Adolesc        ISSN: 0140-1971


  9 in total

1.  Prevalence of depression among adolescents.

Authors:  M K C Nair; Mini K Paul; Ramany John
Journal:  Indian J Pediatr       Date:  2004-06       Impact factor: 1.967

2.  Severity of emotional and behavioral problems among poor and typical readers.

Authors:  Elizabeth Mayfield Arnold; David B Goldston; Adam K Walsh; Beth A Reboussin; Stephanie Sergent Daniel; Enith Hickman; Frank B Wood
Journal:  J Abnorm Child Psychol       Date:  2005-04

3.  Predictors and correlates of follow-up visit adherence among adolescents receiving laparoscopic adjustable gastric banding.

Authors:  Robyn Sysko; Tom B Hildebrandt; Simona Kaplan; Stephanie K Brewer; Jeffrey L Zitsman; Michael J Devlin
Journal:  Surg Obes Relat Dis       Date:  2014-03-28       Impact factor: 4.734

4.  Changes in depressive symptoms among adolescent bariatric candidates from preoperative psychological evaluation to immediately before surgery.

Authors:  Megan B Ratcliff; Jennifer Reiter-Purtill; Thomas H Inge; Meg H Zeller
Journal:  Surg Obes Relat Dis       Date:  2010-06-04       Impact factor: 4.734

5.  The impact of weight loss on depression status in obese individuals subjected to intragastric balloon treatment.

Authors:  Kyriaki Deliopoulou; Anastasia Konsta; Sophia Penna; Pyrros Papakostas; Katerina Kotzampassi
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

6.  The Greek translation of the symptoms rating scale for depression and anxiety: preliminary results of the validation study.

Authors:  Konstantinos N Fountoulakis; Apostolos Iacovides; Soula Kleanthous; Stavros Samolis; Kyriakos Gougoulias; George St Kaprinis; Per Bech
Journal:  BMC Psychiatry       Date:  2003-12-10       Impact factor: 3.630

7.  Reliability, construct and discriminative validity of clinical testing in subjects with and without chronic neck pain.

Authors:  René Jørgensen; Inge Ris; Deborah Falla; Birgit Juul-Kristensen
Journal:  BMC Musculoskelet Disord       Date:  2014-12-04       Impact factor: 2.362

8.  Responsiveness of clinical tests for people with neck pain.

Authors:  René Jørgensen; Inge Ris; Carsten Juhl; Deborah Falla; Birgit Juul-Kristensen
Journal:  BMC Musculoskelet Disord       Date:  2017-12-28       Impact factor: 2.362

9.  Bariatric surgery in adolescents: a prospective randomized controlled trial comparing laparoscopic gastric banding to combined lifestyle interventions in adolescents with severe obesity (BASIC trial).

Authors:  Y G M Roebroek; G F Paulus; E G A H van Mil; A C E Vreugdenhil; B Winkens; C Nederkoorn; C D A Stehouwer; J W M Greve; N D Bouvy; L W E van Heurn
Journal:  BMC Pediatr       Date:  2019-01-28       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.